register

News & Trends - MedTech & Diagnostics

Australian public-private partnership releases first paper on antimicrobial resistance

Health Industry Hub | May 30, 2024 |

Diagnostics & MedTech News: An Australian public-private partnership dedicated to overcoming barriers to commercialisation and advancing antimicrobial stewardship innovations has released its first published paper.

Antimicrobial resistance (AMR) is recognised as one of the greatest scientific challenges of the 21st century, disproportionately affecting people living in low- and middle-income countries. As bacterial pathogens become increasingly resistant to antibiotics, the urgent need for innovative approaches to combat this growing threat is more critical than ever.

Authored by SpeeDx Co-founders Alison Todd AM and Elisa Mokany, the paper features contributions from scientists at The Kirby Institute, Monash University, Peter Doherty Institute and the University of Technology, among others.

The AMR Hub, comprising over 20 organisations, aims to foster multidisciplinary collaborations across various sectors to develop holistic solutions addressing the barriers to commercialising tools designed to minimise the risks of AMR. This initiative emphasises the importance of a comprehensive understanding of the true value of antimicrobial stewardship to inform global policy effectively. It necessitates transformative shifts in societal norms, behaviours, and healthcare practices, along with the restructuring of healthcare financing mechanisms.

“We can no longer only rely on the development of new drugs or indeed diagnostic or stewardship innovations alone to solve the multidimensional problem of AMR. We require a range of low-cost, implementable and rapidly adaptable technologies to support broader social, economic and commercial outcomes,” the authors state.

Focusing its research on sexually transmitted infections, which are increasingly resistant to antibiotics and have limited alternative treatments in development, the AMR Hub is working on several fronts. Investigators are developing novel diagnostics, optimising treatments, identifying tools to detect active bacterial infections, and engaging stakeholders to optimise AMR innovation.

Through a multidisciplinary ecosystem spanning various sectors, the AMR Hub seeks to fast-track the development of adaptable technologies, new antibiotics, and stewardship innovations for prevention. The initiative also addresses the societal, economic, and commercial aspects of AMR solutions, aiming to provide sustainable answers to this complex issue.

The authors conclude, “AMR solutions must be addressed from the perspective of awareness and prevention, requiring highly collaborative private–public partnerships across sectors to secure predictable market opportunities and solutions. To address this need, the AMR Hub fosters an ecosystem of innovative science, technology, engineering and antimicrobial stewardship to mitigate AMR now and provide sustainable solutions into the future.”

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Clinicians unveil Novartis and BMS practice-changing trial results

Clinicians unveil Novartis and BMS practice-changing trial results

Health Industry Hub | June 24, 2024 |

Pharma News: Australia, known for its alarming melanoma rates, witnesses one person diagnosed with the disease every 30 minutes, and […]

More


News & Trends - Pharmaceuticals

Hearts4heart leads awareness week, amid progress in Boehringer Ingelheim and AstraZeneca therapies

Hearts4heart leads awareness week, amid progress in Boehringer Ingelheim and AstraZeneca therapies

Health Industry Hub | June 24, 2024 |

Pharma News: Heart failure is a significant health concern in Australia, affecting approximately half a million people, with over 67,000 […]

More


News & Trends - MedTech & Diagnostics

Cardiologists mark Australian first with Boston Scientific's intracoronary imaging system

Cardiologists mark Australian first with Boston Scientific’s intracoronary imaging system

Health Industry Hub | June 24, 2024 |

MedTech & Diagnostics News: Percutaneous coronary intervention (PCI) has faced substantial complications and failure rates, despite advances in medical devices […]

More


Leadership & Management

AbbVie New Zealand welcomes new leadership amid global moves

AbbVie New Zealand welcomes new leadership amid global moves

Health Industry Hub | June 24, 2024 |

Leadership & Management: In line with its global talent development plan, AbbVie has announced a significant change in leadership for […]

More


This content is copyright protected. Please subscribe to gain access.